BioDelivery Sciences International Inc (BDSI)
$5.59
$0.00 (0.00%)As on 31-Mar-2022 09:30EDT
Market cap
$577 Mln
Revenue (TTM)
$84 Mln
P/E Ratio
6.8
P/B Ratio
3.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$85 Mln
-
ROE
0.6 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
11.7
-
Debt to Equity
0.3
-
Book Value
$1.8
-
EPS
$0.8
-
Face value
--
-
Shares outstanding
103,229,000
10 Years Aggregate
CFO
$-113.94 Mln
EBITDA
$-124.69 Mln
Net Profit
$-148.09 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
| 80.3 | 0.7 | 81.5 | 49.1 | 1.8 | 24.4 | 8.7 |
|
BSE Sensex*
| -13.2 | -5.6 | -6.9 | -10.6 | 5.2 | 7.0 | 10.5 |
|
Company
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
|---|---|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
| -26.2 | -33.5 | 70.8 | 25.3 | 68.6 | -63.5 | -60.1 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 | -5.0 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 | -5.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
5.6 | 577.1 | 166.7 | 84.9 | 44.1 | 57.3 | 6.8 | 3.1 |
| 13.8 | 4,386.6 | 3,045.9 | 122.4 | 13.8 | -- | 37.2 | 105.4 | |
| 41.0 | 5,252.7 | 1,105.3 | 133.3 | 15.9 | 32.7 | 38.3 | 12.7 | |
| 232.3 | 11,955.1 | 708.2 | -188.3 | -25.6 | -293.5 | -- | 218.2 | |
| 67.6 | 13,242.2 | 580.0 | -725.9 | -105.2 | -- | -- | 123.7 | |
| 72.6 | 7,795.9 | 769.1 | 47.9 | 5.4 | 7.5 | 207.5 | 12.2 | |
| 23.6 | 11,876.9 | 4,893.0 | -242.0 | -1.5 | -3.7 | -- | 1.8 | |
| 237.0 | 4,749.7 | 274.5 | 153.6 | 76.6 | 15.8 | 30.9 | 4.8 | |
| 61.9 | 5,500.2 | 288.1 | 22.3 | 17.5 | 34.1 | 363.8 | 51.2 | |
| 69.2 | 4,310.4 | 409.5 | -81.3 | -20.1 | -17.5 | -- | 9.5 |
Shareholding Pattern
View DetailsAbout BioDelivery Sciences International Inc (BDSI)
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its... products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; and Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. The company also provides ELYXYB, a celecoxib oral solution for the treatment of migraine with or without aura in adults; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina. As of March 18, 2022, BioDelivery Sciences International, Inc. operates as a subsidiary of Collegium Pharmaceutical, Inc. Read more
-
CEO & Director
Mr. Jeffrey Allen Bailey
-
CEO & Director
Mr. Jeffrey Allen Bailey
-
Headquarters
Raleigh, NC
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for BioDelivery Sciences International Inc (BDSI)
What is the current share price of BioDelivery Sciences International Inc (BDSI) Today?
The share price of BioDelivery Sciences International Inc (BDSI) is $5.59 (NASDAQ) as of 31-Mar-2022 09:30 EDT. BioDelivery Sciences International Inc (BDSI) has given a return of 1.79% in the last 3 years.
What is the current PB & PE ratio of BioDelivery Sciences International Inc (BDSI)?
The P/E ratio of BioDelivery Sciences International Inc (BDSI) is 6.82 times as on 31-Mar-2022.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
3.76
|
1.70
|
|
2020
|
17.15
|
4.07
|
|
2019
|
-34.27
|
7.52
|
|
2018
|
-6.88
|
7.84
|
|
2017
|
31.26
|
18.61
|
What is the 52 Week High and Low of BioDelivery Sciences International Inc (BDSI)?
The 52-week high and low of BioDelivery Sciences International Inc (BDSI) are Rs -- and Rs -- as of 08-Jun-2026.
What is the market cap of BioDelivery Sciences International Inc (BDSI)?
BioDelivery Sciences International Inc (BDSI) has a market capitalisation of $ 577 Mln as on 31-Mar-2022. As per SEBI classification, it is a company.
Should I invest in BioDelivery Sciences International Inc (BDSI)?
Before investing in BioDelivery Sciences International Inc (BDSI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.